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Abstract 
Causal decomposition analyses can help build the evidence base for interventions that address health 
disparities (inequities). They ask how disparities in outcomes may change under hypothetical 
intervention. Through study design and assumptions, they can rule out alternate explanations such as 
confounding, selection-bias, and measurement error, thereby identifying potential targets for intervention. 
Unfortunately, the literature on causal decomposition analysis and related methods have largely ignored 
equity concerns that actual interventionists would respect, limiting their relevance and practical value. 
This paper addresses these concerns by explicitly considering what covariates the outcome disparity and 
hypothetical intervention adjust for (so-called allowable covariates) and the equity value judgements these 
choices convey, drawing from the bioethics, biostatistics, epidemiology, and health services research 
literatures. From this discussion, we generalize decomposition estimands and formulae to incorporate 
allowable covariate sets, to reflect equity choices, while still allowing for adjustment of non-allowable 
covariates needed to satisfy causal assumptions. For these general formulae, we provide weighting-based 
estimators based on adaptations of ratio-of-mediator-probability and inverse-odds-ratio weighting. We 
discuss when these estimators reduce to already used estimators under certain equity value judgements, 
and a novel adaptation under other judgements. 
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Introduction 
Health disparities represent differences across socially privileged vs. socially marginalized groups that 
society considers inequitable, avoidable, and unjust.1 Interventions that address disparities2 usually affect 
risk factors that are overrepresented among marginalized groups. Often their evidence base draws from 
studies that compare measures of disparities before and after adjustment for a risk factor (the difference 
method3). But the changes seen after such adjustments may be due confounding, selection bias, or 
information bias. The results may not imply that the risk factor studied is the one to be intervened upon. 
Causal decomposition methods4-8 compare to a counterfactual disparity under a hypothetical intervention 
on a target risk factor. They overcome the limitations of simple adjustment through sound study design 
and unverifiable assumptions to rule out alternative explanations (bias). They ask a simple question, how 
disparities in outcomes would change if disparities in a targeted factor (that affects the outcome) were 
removed. 
 
Unfortunately, estimators used for causal decomposition have ignored how disparities and hypothetical 
interventions are defined, limiting their relevance in health equity research. What should a disparity 
measure for the outcome condition on or standardize over? Surveillance reports that track health 
disparities usually adjust for age and sex, but some decomposition estimators adjust for all covariates 
needed to identify a causal effect. Ideally, disparity measures should reflect judgements about what 
constitutes an inequitable difference in the outcome. 
 
Estimators have also ignored how hypothetical interventions are defined. As such, the hypothetical 
intervention, meant to remove disparities in a targeted factor, may not reflect equity concerns that actual 
interventionists would respect. For example, an intervention to remove disparities in healthcare should 
depend on clinical status, but not socioeconomic status which is irrelevant for medical care. Hypothetical 
interventions should reflect judgements about what constitutes an inequitable difference in the target. 
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In this paper, we outline a framework for defining disparities and interventions in causal decomposition 
analysis and provide estimands, non-parametric formulae, and weighting estimators to implement it.  
Specifically, we draw from the bioethics, biostatistics, epidemiology, and health services research 
literatures to consider when covariates are ‘allowable’ for adjusting disparity measures and hypothetical 
interventions. The estimands, formulae, and estimators we propose partition covariates into ‘allowable’ 
sets that define the disparity and intervention, and a ‘non-allowable’ set that is needed to identify the 
causal effect. Under a motivating example, we use this framework to examine estimators of natural and 
interventional effects (mediation analysis) and discrimination (Oaxaca-Blinder decomposition) and the 
equity judgements they imply and consider a meaningful alternative. 
 
Motivating Example and Notation 
To fix ideas, we consider a motivating example from clinical medicine: how to reduce disparities in 
hypertension control by intervening on decisions to intensify antihypertensive treatment.9 Suppose a 
healthcare system administrator wants to address disparities in hypertension control across race/ethnicity 
(𝑅) and tasks us with forming a cohort to study them. Patients are enrolled at their first visit if, on the 
basis of their systolic blood pressure (𝐿0), they can be classified as hypertensive (𝑌0;1=yes, 𝐿0 ≥ 140 mm 
Hg, 0 =no, 𝐿0 < 140 mm Hg). For simplicity we ignore diastolic blood pressure. At six months follow-up 
systolic blood pressure (𝐿1) and uncontrolled hypertension (𝑌1;1=yes, 𝐿1 ≥ 140 mm Hg, 0 =no, 𝐿1 < 140 
mm Hg) are measured. Disparities in hypertension control may arise through clinical uncertainty.10 When 
providers know less about their patients’ medical condition (due to poor provider communication, for 
example) their decision-making may rely on stereotypes. We are interested in how eliminating disparities 
in treatment decisions would affect disparities in hypertension control. 
 
We thus record the patient’s race 𝑅 where 𝑅 = 𝑟 represents membership in the marginalized group (e.g., 
blacks) and 𝑅 = 𝑟′ the privileged group (e.g., whites), demographics age 𝑋𝑖 and sex 𝑋𝑖𝑖, whether 
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antihypertensive treatment was intensified at the initial visit (𝑀; 1=yes,0=no) as well as socioeconomic 
factors such as educational attainment 𝑋𝑖𝑖𝑖 and private health insurance 𝑋𝑖𝑣 that may implicitly affect 
treatment and hypertension control. We also record diabetes diagnosis 𝑋𝑣 which, as a marker of 
cardiovascular risk, predicts blood pressure and may influence treatment decisions. We assume that some 
associations between race/ethnicity 𝑅, 𝑋, and 𝐿0  are driven by historical processes 𝐻 (e.g., slavery, Jim 
Crow, federal and local housing policies) as depicted in our causal graph (Figure 1), provided for 
intuition. We allow that unmeasured factors 𝑈 may correlate repeated measures of systolic blood pressure 
𝐿0 and 𝐿1 and possibly other variables but do not independently predict treatment intensification 𝑀. 
 
To develop general formulae, we denote covariates used to define the disparity in hypertension control 
(the outcome) as 𝐶, and covariates used to further guide treatment intensification (the targeted factor) as 
𝑄𝑚. We let 𝐺𝑚|𝑞𝑚𝑐 denote a hypothetical stochastic intervention
11,12 to set the conditional distribution of 
treatment intensification 𝑀 among blacks to the distribution among whites with identical values for 𝑄𝑚 
and 𝐶, denoted as 𝑃(𝑚|𝑅 = 𝑟′, 𝑞𝑚, 𝑐). Suppose we choose 𝐶 as 𝑋𝑖 and 𝑋𝑖𝑖, 𝑄𝑚 as 𝐿0 and 𝑋𝑣. Among 
blacks, under 𝐺𝑚|𝑞𝑚𝑐, their treatment is intensified according to a random draw from the distribution 
among whites who share the same values for 𝑋𝑖, 𝑋𝑖𝑖 , 𝐿0 and 𝑋𝑣. 
  
Meaningful Disparity and Intervention Definition 
In causal decomposition analysis, we are concerned with two measures of disparity. First there is the 
disparity in the outcome, and how that might change upon intervention. The second is the disparity in a 
targeted factor (a determinant of the outcome) that the hypothetical intervention is to address. Defining a 
disparity is a complex process involving decisions about what is fair and just in the distribution of health 
and its determinants.13-17 We focus on which covariates are considered ‘allowable’ for adjustment in 
defining outcome disparities and interventions, and how these choices relate to equity value judgements. 
The notion of allowability has been discussed in the context of medical goods and used to define 
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healthcare disparities in ‘counterfactual’ terms.18,19 Our discussion broadens the concept to health 
disparities and decomposition analysis but avoids counterfactual definitions of disparity. 
 
Allowability 
In the bioethics literature, many define a health disparity as an avoidable, systematic difference between 
socially advantaged vs. marginalized groups, wherein the marginalized group is further disadvantaged on 
health.20,21 In the health services research literature, disparities in healthcare are often defined using the 
Institute of Medicine definition, as differences in healthcare services that are not due to differences in 
underlying health needs or preferences.18,22 A careful reading of these definitions recognizes that, in 
defining disparities, both avoid detailing a causal model for how they arise. While there are some 
objections to this,19 there are practical and scientific reasons why this may be desirable.20,21 
 
These definitions encourage us to consider what sources of difference might be considered fair or 
‘allowable’ and to take these ‘off the table’ when measuring disparity. By corollary, ‘non-allowable’ 
sources are those that are unjust and thus contribute to disparity. For health outcomes, allowable sources 
typically include demographic factors such as age and sex.23 For medical goods, allowable sources 
typically include clinical status, history, and presentation.18,22 All other factors are often considered non-
allowable. Although these represent default choices in many studies, other positions become clear when 
issues of modifiability, amenability to intervention, social contract, and purpose are considered. 
 
Modifiability & Amenability to Intervention 
In defining health disparity measures, it is common to see innate ‘non-modifiable’ factors such as 
chronological age, sex, and even somatic genotype treated as allowable and adjusted for. While society 
has profound power over the historical distribution of innate factors (through war, genocide, racism, and 
policy), for a fixed living population, it has no ability to modify them. On these grounds, some might 
argue that innate differences leading to differences in health are not necessarily unfair.17 
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Some object to using strict modifiability to decide whether to treat a covariate as allowable.14,20 While 
society cannot change age, sex, or genotype, it can address their effects. Social programs can be made age 
and sex appropriate, increasing their effectiveness. Targeted cancer therapies have been developed for 
genetic profiles. If one considers a health disparity as any difference placing a marginalized group at 
further disadvantage, and society can address the effects of innate characteristics, one might then consider 
their differences as contributors to disparity when society fails to adequately respond to them. Thus, 
innate differences could be considered non-allowable and not adjusted for. This principle best applies 
when the marginalized group is disadvantaged on the innate factor. Otherwise, adjusting for innate factors 
could mask unjust differences. 
 
Consider these arguments in our motivating example. First, we have pre-existing conditions. Blacks 
disproportionately encounter barriers to care, such as lack of health insurance, leading to higher 
prevalence of chronic conditions at baseline encounters. By that point, a patient’s clinical history is 
beyond the control of the clinician and healthcare system. However, this history can be managed for 
better prognosis, for example by consulting a specialist. Clinical guidelines recommend tailored treatment 
protocols for patients with diabetes, kidney disease, and heart failure. Thus, healthcare can respond to 
disparate pre-existing conditions. Failure to do so equitably would contribute to unjust differences in 
prognosis. Second, we have age. Blacks are typically younger than whites, and increasing age predicts 
poor hypertension control. Not adjusting for age would mask unjust differences in hypertension control. 
Overall, when measuring disparities in prognosis, if there are disparities in pre-existing conditions, one 
might reasonably decide to treat them as non-allowable (and not adjust). If blacks are younger than 
whites, one might reasonably decide to treat age as allowable (and adjust). 
 
Social Contract 
When defining hypothetical interventions that address disparities in goods, allowability choices should 
consider the social contract. The distribution of any good is ideally governed by norms and conditions 
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that society has agreed upon as fair and just. That is, we believe that decisions about goods are fair if and 
only if they are based upon ideal criteria that reflect our shared norms and values. That is, in defining 
interventions on goods, we treat our idealized criteria as allowable. 
 
These arguments have clear implications for interventions that address medical goods. Medical ethics 
dictates that decisions be clinically appropriate. For addressing disparities in diagnosis, allowable sources 
could include information needed to accurately differentiate between syndromes, such as presentation and 
test results. For addressing disparities in treatment, allowable sources could include factors that indicate 
and modify treatment effectiveness, such as comorbid conditions.22 For addressing disparities in social 
conditions, perhaps through a community health worker, allowable sources could include social needs. In 
our motivating example, the hypothetical intervention to intensify treatment would need to consider age, 
sex, baseline blood pressure, and diabetes but ignore socioeconomic status. Otherwise, the intervention 
would not only be unethical, but also inequitable. It would preserve racial differences in treatment that 
operate through racial differences in socioeconomic status.5 Observing the social contract reflects that our 
goal is not equal treatment, but equitable treatment.22 
 
When defining disparities in outcomes that are goods, allowability choices should also consider the social 
contract. This again would treat idealized decision-inputs as allowable. An exception can be made when 
one seeks to reduce racial differences in goods by eliminating disparities in a criterion governing their 
distribution. Suppose one were studying a lower rate of listing for transplantation among blacks vs. 
whites. Listing decisions often consider anticipated social support. An overall racial difference in listing 
partly due to differences in social support might be concerning, even considered disparate. Here, social 
support could be treated as non-allowable (and not adjusted for) so it could be studied as a hypothetical 
intervention. 
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Purpose 
In defining outcome disparity measures, allowability must also consider their use. In surveillance and 
quality assessment, disparity measures can track how well a society, institution, or actor meets objectives. 
In these settings, when factors the actor does not control are treated as non-allowable (and not adjusted 
for), this can lead to deleterious effects. In our example, if an external body were benchmarking clinical 
practices based on disparities in hypertension control rates without any risk adjustment, those that serve 
marginalized populations with comorbidities may score worse. Those clinics might then be incentivized 
to avoid complex patients.24 When causal decomposition analysis is applied to performance assessment 
measures, it is advisable to study the one used in practice, which might call for pre-existing conditions to 
be treated as allowable, for the sake of risk adjustment.25 
 
Measurement 
We now turn to how outcome disparities are defined in our causal decomposition analysis. For the 
outcome, we define disparity as the mean outcome difference across levels of social groups, where the 
distribution of allowable covariates is standardized. Here, we use the pooled distribution as the standard. 
In defining the hypothetical intervention, which is intended to remove disparities in a targeted factor, we 
adjust for allowable covariates through conditioning. We have chosen these simple statistical measures of 
disparity because the observed disparities can be estimated directly from the data with minimal 
assumptions and are consistent with widely adopted definitions of disparity.20-22 
 
These definitions assume common support for the allowable covariates across race. Otherwise adjustment 
would fail to remove the influence of allowable covariates. This is a relatively benign assumption because 
it is the non-allowable covariates (those not adjusted for) that contribute to disparities and are often 
‘structurally confounded’ with race. Another constraint is temporality, where allowable covariates are 
defined prior to the outcome and target and are ideally measured by cohort entry. 
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Meaningful Disparity Decomposition 
Here, we present general causal decomposition estimands defined by allowable covariates for the 
disparity in hypertension control (the outcome) and the hypothetical intervention to intensify treatment 
(the targeted intervention). Under assumptions, we provide identifying formulae and weighting-based 
estimators. Importantly, these formulae and estimators can incorporate confounders that are considered 
non-allowable, without using them to define outcome disparities or the intervention. All expressions 
condition on the population of interest, persons with uncontrolled hypertension at baseline. 
 
Definition 
The observed disparity in hypertension control is: 
∑ 𝐸[𝑌1|𝑟, 𝑐]𝑃(𝑐) − ∑ 𝐸[𝑌1|𝑟
′, 𝑐]𝑃(𝑐)𝑐𝑐          (1) 
The change in disparity under the intervention 𝐺𝑚|𝑞𝑚𝑐 to remove the disparity in treatment intensification 
is: 
∑ 𝐸[𝑌1|𝑟, 𝑐]𝑃(𝑐) − ∑ 𝐸[𝑌1(𝐺𝑚|𝑞𝑚𝑐)|𝑟, 𝑐]𝑃(𝑐)𝑐𝑐         (2) 
The remaining disparity after the intervention 𝐺𝑚|𝑞𝑚𝑐 is: 
∑ 𝐸[𝑌1(𝐺𝑚|𝑞𝑚𝑐)|𝑟, 𝑐]𝑃(𝑐) − ∑ 𝐸[𝑌1|𝑟
′, 𝑐]𝑃(𝑐)𝑐𝑐        (3) 
The covariates 𝐶 used to adjust the disparity are considered outcome-allowable. The covariates 𝐶 and 𝑄𝑚 
used to define the intervention are considered target-allowable, where 𝑄𝑚 is exclusively target-allowable. 
 
Identification 
The counterfactual disparity reduction (2) and residual (3) are not observed. These expressions can be 
identified with observational data under assumptions (see eAppendix for formal statements). Among 
blacks 𝑅 = 𝑟, we assume conditional exchangeability,26 or no unmeasured confounding of the 
relationship between treatment intensification 𝑀 and hypertension control 𝑌1: given the allowables 𝐶 and 
𝑄𝑚 and additional non-allowable confounders 𝑄𝑣, the potential outcomes under treatment intensification 
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are independent of observed treatment intensification. We further assume positivity among blacks,26 
where there is a positive conditional probability of each observed value for treatment intensification 𝑀 
given the allowable covariates 𝐶 and 𝑄𝑚 used to define the estimands and the non-allowable covariates 
𝑄𝑣 to help identify them. We also assume common support across race 𝑅 for the targeted factor and 
allowable covariates (jointly). Finally, we assume consistency26 among blacks, that their outcomes would 
be the same regardless if their values were merely observed or set by hypothetical intervention. These 
assumptions are strong and the ability to satisfy them will vary across substantive settings.27 
 
When these assumptions hold, we can identify the proportion with controlled hypertension among blacks 
under 𝐺𝑚|𝑞𝑚𝑞𝑟𝑐 as: 
∑ 𝐸[𝑌1(𝐺𝑚|𝑞𝑚,𝑐)|𝑟, 𝑐]𝑃(𝑐)𝑐   
= ∑ 𝐸[𝑌1|𝑟, 𝑚, 𝑞𝑣 , 𝑞𝑚, 𝑐]𝑚,𝑞𝑣,𝑞𝑚,𝑐 𝑃(𝑚|𝑟
′, 𝑞𝑚, 𝑐)𝑃(𝑞𝑣|𝑟, 𝑞𝑚, 𝑐)𝑃(𝑞𝑚|𝑟, 𝑐)𝑃(𝑐)    (4) 
 
This allows us to identify the disparity reduction (2) given that the observed proportion of controlled 
hypertension among blacks is: 
∑ 𝐸[𝑌1|𝑟, 𝑐]𝑃(𝑐)𝑐   
= ∑ 𝐸[𝑌1|𝑟, 𝑚, 𝑞𝑣 , 𝑞𝑚, 𝑐]𝑚,𝑞𝑣,𝑞𝑚,𝑐 𝑃(𝑚|𝑟, 𝑞𝑣, 𝑞𝑚, 𝑐)𝑃(𝑞𝑣|𝑟, 𝑞𝑚, 𝑐)𝑃(𝑞𝑚|𝑟, 𝑐)𝑃(𝑐)   (5) 
 
From (7) we can identify the disparity residual (3) given that the observed proportion of controlled 
hypertension among whites is: 
∑ 𝐸[𝑌1|𝑟
′, 𝑐]𝑃(𝑐)𝑐   
= ∑ 𝐸[𝑌1|𝑟
′, 𝑚, 𝑞𝑚, 𝑐]𝑚,𝑞𝑚,𝑐 𝑃(𝑚|𝑟
′, 𝑞𝑚, 𝑐)𝑃(𝑞𝑚|𝑟
′, 𝑐)𝑃(𝑐)      (6) 
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Estimation 
Equations (4)-(6) could be estimated using Monte Carlo integration similar to the parametric g-formula,28 
using correctly specified parametric models, as in other contexts.29-33 A key distinction from these 
proposals is what the models condition on. The outcome models condition on: (a) allowable and non-
allowable covariates in the observed and counterfactual scenarios for blacks (b) only allowable covariates 
in the observed scenario among whites. The target factor models condition on: (a) allowable and non-
allowable covariates in the observed scenario for blacks (b) only allowable covariates in the observed 
scenario for whites and the counterfactual scenario for blacks. Other algorithms are possible (see 
eAppendix) but this one does not require non-allowables to be measured or even defined among whites. 
 
Because simulation-based approaches are computationally intensive and require correctly specifying 
several models, we present two simple weighting-based estimators that can be implemented with standard 
statistical software routines (briefly described in the e-Appendix). In the health equity context, these 
encompass existing estimators in the economics,34-36 sociology,37,38 biostatistics and epidemiology 
literatures,39-44 including those used to identify natural direct and indirect effects,45,46 path-specific 
effects,47 interventional effects,11,12,42 and discrimination48,49 under certain allowability choices, and novel 
adaptations under others. 
 
Ratio of Mediator Probability Weighting Estimation (RMPW) 
The first weighting procedure is based on a ratio of probabilities for treatment intensification 𝑀. The 
disparity reduction (2) and residual (3) under the intervention 𝐺𝑚|𝑞𝑚𝑐 are estimated by comparing 
weighted means for blacks and whites. First, we estimate the observed proportion with controlled 
hypertension 𝑌1 among blacks, standardized for the outcome-allowable covariates 𝐶:  
∑ 𝐸[𝑌1|𝑟, 𝑐]𝑃(𝑐)𝑐 =  𝐸[𝐸[𝑌1 × 𝐼(𝑟) × 𝑤𝑟|𝑞𝑣 , 𝑞𝑚, 𝑐]]      (7a) 
where the weight 𝑤𝑟 =
𝑃(𝑟)
𝑃(𝑟|𝑐)
          (7b) 
12 
 
Next, we estimate the observed proportion with controlled hypertension 𝑌1 among whites, standardized 
for the outcome-allowable covariates 𝐶: 
∑ 𝐸[𝑌1|𝑟
′, 𝑐]𝑃(𝑐)𝑐 = 𝐸[𝐸[𝑌1 × 𝐼(𝑟
′) × 𝑤𝑟′|𝑞𝑚, 𝑐]]      (8a) 
where the weight 𝑤𝑟′ =
𝑃(𝑟′)
𝑃(𝑟′|𝑐)
          (8b) 
Last, we estimate the counterfactual proportion with controlled hypertension 𝑌1 among blacks under the 
intervention 𝐺𝑚|𝑞𝑚𝑐, which depends on the outcome- and target-allowable covariates 𝐶 and 𝑄𝑚. Like the 
observed outcomes, the estimated counterfactuals are standardized for the outcome-allowable covariates 
𝐶: 
∑ 𝐸[𝑌1(𝐺𝑚|𝑞𝑚𝑐)|𝑟, 𝑐]𝑃(𝑐)𝑐 = 𝐸[𝐸[𝑌1 × 𝐼(𝑚) × 𝐼(𝑟) × 𝑤𝑟
𝑟𝑚𝑝𝑤
|𝑞𝑣 , 𝑞𝑚, 𝑐]]   (9a) 
where the weight 𝑤𝑟
𝑟𝑚𝑝𝑤 =
𝑃(𝑚|𝑟′,𝑞𝑚,𝑐)
𝑃(𝑚|𝑟,𝑞𝑣,𝑞𝑚,𝑐)
×
𝑃(𝑟)
𝑃(𝑟|𝑐)
       (9b) 
The counterfactual disparity reduction is obtained by subtracting (9a) from (7a), and the residual by 
subtracting (8a) from (9a). 
 
Inverse Odds Ratio Weighting Estimation (IORW) 
The second weighting procedure is based on a ratio of inverted odds for race 𝑅. The disparity reduction 
(2) and residual (3) under the intervention 𝐺𝑚|𝑞𝑚𝑐 are estimated by comparing weighted means for blacks 
and whites. The observed proportions with controlled hypertension 𝑌1 among black and whites, 
standardizing for the outcome-allowable covariates 𝐶, are respectively given in (7a) and (8a). The 
counterfactual proportion with controlled hypertension 𝑌1 among blacks under the intervention 𝐺𝑚|𝑞𝑚𝑞𝑟𝑐, 
standardized for the outcome-allowable covariates 𝐶, is given by: 
∑ 𝐸[𝑌1(𝐺𝑚|𝑞𝑚𝑐)|𝑟, 𝑐]𝑃(𝑐)𝑐 = 𝐸[𝐸[𝑌1 × 𝐼(𝑚) × 𝐼(𝑟) × 𝑤𝑟
𝑖𝑜𝑟𝑤|𝑞𝑣 , 𝑞𝑚, 𝑐]]   (10a) 
where the weight 𝑤𝑟
𝑖𝑜𝑟𝑤 =
𝑃(𝑟′|𝑚,𝑞𝑚,𝑐)
𝑃(𝑟|𝑚,𝑞𝑣,𝑞𝑚,𝑐)
𝑃(𝑟′|𝑞𝑚,𝑐)
𝑃(𝑟|𝑞𝑣,𝑞𝑚,𝑐)
×
𝑃(𝑚|𝑞𝑚,𝑐)
𝑃(𝑚|𝑞𝑣,𝑞𝑚,𝑐)
×
𝑃(𝑟)
𝑃(𝑟|𝑐)
     (10b) 
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Note that when all covariates are treated as allowable, the middle term in (10b) cancels and does not need 
to be estimated. As with RMPW, the disparity reduction is estimated by subtracting (10a) from (7a), and 
the disparity residual by subtracting (8a) from (10a). 
 
A Closer Look at Existing Estimators 
Estimators of natural and path-specific effects, their analogues, and the Oaxaca-Blinder decomposition 
are often applied to study disparities. We now use our general expressions to examine these estimators 
and the equity value judgements they convey (see e-Appendix for a formal discussion). Many of these 
estimators were developed in the context of mediation analysis to study the effects of exposures and 
others to measure discrimination.5,50 When used to study disparities, the decomposition estimands they 
identify are not always meaningful. The problem arises because these of how they adjust for covariates. 
They implicitly define outcome disparities and interventions in ways that often ignore principles of 
modifiability, amenability to intervention, social contract, and purpose. Our generalized estimators 
explicitly consider allowable and non-allowable partitions, so users can be more intentional. 
 
Natural Indirect Effect Analogue 
Estimators of the natural direct and indirect effects include the regression approaches of Valeri and 
VanderWeele51 and Breen et al.,52 ratio of mediator probability weighting of Hong,37,38 natural effect 
models of Lange et al.,39 inverse odds ratio weighting of Tchetgen Tchetgen,41 propensity-score weighting 
of Huber,53 imputation approaches of Albert54 and Vansteelandt, Bekaert and Lange,55 simulation 
approaches of Imai et al.29 and Wang et al,30 and targeted maximum likelihood estimation of Zheng.44 In 
our example, these estimate the observed disparity (1) by conditioning the entire analysis on all covariates 
needed to de-confound the relationship between treatment decisions 𝑀 and hypertension control 𝑌 (or by 
standardizing across race). This renders all covariates as outcome-allowable. This is problematic because 
pre-existing diabetes 𝑋𝑣, low educational attainment 𝑋𝑖𝑖𝑖 and lack of private insurance 𝑋𝑖𝑣 are risk factors 
for poor hypertension control and are more common among blacks. Moreover, their effects on 
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hypertension control are amenable to intervention. Thus, treating these pre-existing conditions as 
outcome-allowable artefactually diminishes the amount of unjust difference to be studied. Furthermore, 
these approaches estimate the disparity reduction (2) by allowing the hypothetical intervention on 
treatment intensification to depend on all covariates. This renders all covariates as target-allowable. This 
is problematic because, by ignoring the social contract, racial differences in treatment intensification that 
operate through racial differences in educational attainment would persist. 
 
Path-Specific Effect Analogues 
Estimators of path-specific effects and their interventional analogues have also been applied to study 
disparities. In our example, all would estimate the observed disparity as (1) by conditioning the entire 
analysis on age 𝑋𝑖 and sex 𝑋𝑖𝑖, treating them as outcome-allowable. But they differ in how they would 
treat covariates affected by race, which in our example are educational attainment 𝑋𝑖𝑖𝑖 , private health 
insurance 𝑋𝑖𝑣, diabetes 𝑋𝑣, and baseline blood pressure 𝐿0. The weighting estimator proposed by 
VanderWeele, Vansteelandt and Robins42 would treat such covariates as non-allowable. Therefore, in 
estimating the disparity reduction as (2), this intervention to set treatment decisions would only depend on 
age and sex. This is problematic because our society has generally agreed that treatment decisions should 
depend on clinical needs. Respecting the social contract would assign clinical needs as target-allowable. 
In contrast, the weighting approach proposed by Zheng and Van Der Laan44  (and that of Miles et al.,40 
under a no-interaction assumption6) would estimate the disparity reduction (2) by treating all race-
affected covariates as allowable. This intervention to set treatment decisions would depend not only on 
clinical needs but also educational attainment and private health insurance. This is problematic because, 
as we argued with the natural indirect effect analogue, medical treatment decisions should not hinge on 
educational attainment or private health insurance. Finally, a simulation-based estimator proposed by 
Vansteelandt and Daniel31 makes the same allowability choice as VanderWeele, Vansteelandt and 
Robins42 and the path-specific indirect effect they identify does not map to the disparity reduction (2) in 
the presence target-outcome confounders affected by race, as in our motivating example. 
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Oaxaca-Blinder Decompositions 
The Oaxaca-Blinder Decomposition48,49 has also been applied to study disparities. The approach estimates 
the disparity reduction (2) by using linear models to regress the outcome on treatment intensification and 
all covariates and carrying out a ‘detailed decomposition’ with respect to treatment intensification.5 This 
studies a marginal racial difference in hypertension control, with a hypothetical intervention to remove 
marginal differences in treatment intensification. Effectively, it treats all covariates as neither outcome-
allowable nor target-allowable, leaving 𝐶 and 𝑄𝑚 empty. All covariates are treated as non-allowable and 
included through 𝑄𝑣 only to control for confounding. Alternatively, re-weighting estimators
34,35 of the 
Oaxaca-Blinder decomposition have been widely used. Here, the racial difference in hypertension control 
conditions on no covariates, leaving 𝐶 empty, but the hypothetical intervention conditions on all 
covariates, through 𝑄𝑚. Thus, no covariates are treated as outcome-allowable but all are treated as target-
allowable. These allowability assignments share the problems listed for the estimators of natural and path-
specific effect analogues. 
 
A Meaningful Estimator 
In our example, the many existing estimators we examined do not map to meaningful estimands because 
of the implicit allowability choices they make, which are summarized in Table 1. We could, in adapting 
the general formulae and weighting expressions, choose to deem age 𝑋𝑖 and sex 𝑋𝑖𝑖 as outcome-and 
target-allowable, respecting principles of modifiability and amenability to intervention, and deem baseline 
blood pressure 𝐿0 and diabetes 𝑋𝑣 as exclusively target-allowable, respecting the social contract. Doing 
so would treat educational attainment 𝑋𝑖𝑖𝑖 and private health insurance 𝑋𝑖𝑣 as non-allowable, using them 
to adjust for confounding but not define the outcome disparity or hypothetical intervention. 
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Discussion 
We have shown how causal decomposition analysis can incorporate equity concerns by partitioning 
covariates into allowable and non-allowable subsets (the latter used for identification). When a covariate 
is deemed outcome-allowable, its contribution is removed so that we are left with a difference we 
consider unjust. The hypothetical intervention to remove disparities in a targeted factor is administered 
within levels of target-allowable covariates, so that treatment is equitable. We have discussed how 
allowability choices can consider issues of modifiability, amenability to intervention, social contract, and 
purpose, reflecting value judgements about equity. We provided generalized non-parametric formulae and 
weighting-based estimators that are defined in terms of allowable and non-allowable subsets. Last, we 
discussed when these estimators reduce to existing ones under certain value judgements, unifying and 
clarifying various approaches from biostatistics, epidemiology, economics, and sociology in the health 
equity context. 
 
Our proposal has implications for study design in causal decomposition analysis. Researchers should 
consider variables needed to sensibly measure disparity, and whether these are defined and measured with 
common support among blacks and whites. When our estimators are used, the non-allowables only need 
to be defined and measured among blacks. This is important given the way in which some non-allowable 
constructs, such as racial discrimination, may occur almost exclusively with racial/ethnic minorities.8 
 
Regarding disparity definition, by only discussing additive measures of disparity across more vs. less 
marginalized groups, and by ignoring group size, we implicitly entertained several value 
judgements.14,15,20 Our approach involved a single axis of disadvantage, but could be extended to study 
intersectional disparities.7,8,56 Regarding disparity measurement, selected populations induce correlations 
between race and outcomes through collider-stratification, as in our example. As long as selection occurs 
pre-target, it does not affect causal identification.4 The impact and interpretation of this important issue 
for disparity measurement is left for future work.  
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Regarding estimation, our approach focused on a single target, and continuous and (even non-rare) binary 
mean outcomes, allowing for race-target, race-covariate, target-covariate, and covariate-covariate 
interactions. Considering earlier work on RMPW and IORW estimation,39,41 our approach should extend 
to multiple targets, distributional outcomes, repeated outcomes, and survival analysis but this is left for 
future work. Regarding the intervention, we focused on categorical targets. Extensions to continuous 
targets could involve estimating relative conditional densities, expanding on earlier work,34,35 but this may 
prove difficult with several covariates. The weights must be estimated using correctly specified models 
(see eAppendix). Our focus was on conceptual issues in definition and their relevance for estimation. 
Future work will consider practical guidance in implementation. 
 
Conclusion 
We have outlined a framework for incorporating equity concerns into causal decomposition analysis. Our 
contributions should be of wide interest, particularly when there are baseline differences in non-
modifiable factors or when hypothetical interventions concern socially distributed goods. 
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Table 1. Allowability Designations of Estimators 
 𝐶 𝑄𝑚 𝑄𝑣 
1. Oaxaca-Blinder Decomposition via Linear 
Models48,49: All covariates are considered 
non-allowable 
⊘ ⊘ 𝑋𝑖 , 𝑋𝑖𝑖 , 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , 𝑋𝑣 , 𝐿0 
2. Oaxaca-Blinder Decomposition Estimator 
via Reweighting Functions: No covariates 
considered outcome-allowable; all covariates 
are considered target-allowable34,35 
⊘ 𝑋𝑖 , 𝑋𝑖𝑖 , 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , 𝑋𝑣 , 𝐿0 ⊘ 
3. Natural Direct/Indirect Effect Analogue 
Estimators29,37-39,44,51-53: All covariates are 
considered outcome- and target-allowable 
𝑋𝑖 , 𝑋𝑖𝑖 , 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , 𝑋𝑣 , 𝐿0 ⊘ ⊘ 
4. Path-Specific Effect Analogue (I & II) 
Estimator31,42: Demographic covariates 
considered outcome- and target-allowable; 
remaining covariates considered non-
allowable 
𝑋𝑖 , 𝑋𝑖𝑖 ⊘ 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , 𝑋𝑣 , 𝐿0 
5. Path-Specific Effect Analogue (III) 
Estimator40,43: Demographic covariates 
outcome- and target-allowable; remaining 
covariates considered target-allowable 
𝑋𝑖 , 𝑋𝑖𝑖 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , 𝑋𝑣 , 𝐿0 ⊘ 
6. A Meaningful Estimator: Demographic 
covariates considered outcome- and target-
allowable; clinical covariates considered 
target-allowable; socioeconomic covariates 
considered non-allowable 
𝑋𝑖 , 𝑋𝑖𝑖 𝑋𝑣 , 𝐿0 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 
Abbreviations: 𝐶 outcome- (and target-) allowable covariates, 𝑄𝑚 exclusively target-allowable covariates, 𝑄𝑣 non-allowable covariates; List of 
covariates include 𝑋𝑖 age, 𝑋𝑖𝑖 sex, 𝑋𝑖𝑖𝑖 educational attainment, 𝑋𝑖𝑣 private health insurance,  𝑋𝑣 diabetes, 𝐿0 baseline blood pressure 
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Figure 1. Causal diagram depicting relationships between history (𝐻), race (𝑅), demographics age and 
sex (𝑋𝑖 and 𝑋𝑖𝑖), socioeconomic covariates educational attainment and private health insurance (𝑋𝑖𝑖𝑖 
and 𝑋𝑖𝑣), diabetes (𝑋𝑣), baseline and follow-up blood pressure (𝐿0 and 𝐿1), hypertensive status at 
baseline and subsequent control (𝑌0 and 𝑌1), and treatment intensification 𝑀. Additional arrows could 
be allowed from 𝑈 to 𝑋𝑖𝑖𝑖 , 𝑋𝑖𝑣 , and 𝑋𝑣. The box around 𝑌0 indicates that the population is restricted to 
those with hypertension at baseline. 
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Proofs 
 
Notation. 
 
Let the subscript t index the timing of measurement for variable Vt (0=current visit, 1=next visit), with the 
convention dropped for some variables measured at the current visit e.g., V0=V. Let L0 and L1 equal, 
respectively, a patient’s outcome (e.g., blood pressure) at the current and follow-up visit. Let Y0 and Y1 equal, 
respectively, a patient’s diagnosis based on L (e.g., uncontrolled hypertension; 1=yes,0=no) at the current 
and follow-up visit. Let M equal a determinant of L1 that we want to intervene upon to alter the distribution of 
Y1 (e.g., decision to intensify antihypertensive treatment; 1=yes,0=no). Let Xiii, Xiv, and Xv (educational 
attainment, private health insurance, and diabetes, respectively) be measured common causes of L0, M, and 
L1, let Xi and Xii equal common causes of these variables (sex and age, respectively), let R equal a binary 
variable that defines a socially marginalized population (e.g., race), let H equal sociopolitical forces (e.g., 
racism) that creates association between R and X. Let U equal an unmeasured source of correlation between 
L0 and L1. (Our results still hold even if this unmeasured cause affects Xi-v). Let V(w) equal the value that V 
would take (i.e. potential outcome, counterfactual) had W been set to value w. Let the symbol A ∐ 𝐵 |V denote 
statistical independence between A and B given V. For intuition, see eFigure 1 for a causal graph relating 
these variables.  
 
 
  
eFigure 1. Causal graph describing the the R--Y1 association through H,Xi-v,L0,Y0,M, and L1 
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Definition. 
 
General formulation. 
 
As defined above, the variable R represents the social status across which the disparity will be measured. R=r 
will represent a marginalized group and R=r’ the privileged group. (It is entirely possible to consider the 
following proposition with these values switched). The population of interest consists of all patients with 
uncontrolled hypertension at baseline (Y0=1). Consider an intervention to set the distribution of a target 
variable M (antihypertensive treatment intensification) to affect disparities in the outcome Y1, whether or not 
hypertension is subsequently uncontrolled. We will define three variable sets. The first variable set C defines 
the covariates that are considered both outcome- and target-allowable. The second variable set Qm defines 
covariates that are additionally considered target-allowable but not outcome-allowable. The third variable set 
defines covariates that, in addition to those in C and Qm, are needed for causal identification but are 
nonetheless considered non-allowable. It is permissible to partition the covariates such that some sets remain 
empty. For example, if C contains all covariates, then by definition Qm and Qv are empty. All expressions that 
follow condition on the population of interest, patients with hypertension. 
 
Proposition. 
 
Consider an intervention Gm|q_m,c among those with R=r to set the distribution of M according to the observed 
distribution P(m|R=r’,qm,c). The observed disparity prior to intervention, and the reduced and residual 
disparity after intervention are given, respectively, as: 
 
i) ∑c E[Y1|R=r,c]P(c) - ∑c E[Y1|R=r’,c]P(c) 
ii) ∑c E[Y1|R=r,c]P(c) - ∑c E[Y1(Gm|q_m,c)|R=r,c]P(c) 
iii) ∑c E[Y1(Gm|q_m,c)|R=r,c]P(c) - ∑c E[Y1|R=r’,c]P(c) 
 
Identification. 
 
As stated, let Qv denote additional variables needed for conditional exchangeability beyond Qm and C. 
 
Assumptions. 
 
A) Conditional exchangeability among R=r 
 
Y1(m)∐ m|R=r, qv,qm,c for all m among R=r 
 
B1) Positivity among R=r:  
 
P(m|R=r,qv,qm,c)>0 for qv,qm,c with P(qv,qm,c|R=r)>0 for all m in the support of M among R=r 
 
B2) Common support across R: 
 
P(qm,c|R=r)>0 if P(qm,c|R=r’)>0 and P(m|R=r,qm,c)>0 if P(m|R=r’,qm,c)>0 for qm,c with P(qm,c|R=r’)>0. 
 
C) Consistency:  
 
Mi=m ⇒ Y1i=Y1i(m) 
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Following Jackson & VanderWeele 2018 and Jackson 2018 we have among those with R=r: 
 
∑c E[Y1(Gm|q_m,c =m)|R=r,c]P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,Gm|q_m,c=m,qm,c]P(Gm|q_m,c=m|R=r,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,qm,c]P(Gm|q_m,c=m|R=r,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,qm,c]P(M=m|R=r’,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1(m)|R=r,qv,qm,c]P(M=m|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1(m)|R=r,m,qv,qm,c]P(M=m|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c)   (1) 
 
Where the first (and fourth) equality follow by the total law of probability, the second by definition of Gm|q_m,c 
as random among R=r given Qm and C, the third by definition of Gm|q_m,c among R=r as a random draw from 
the distribution P(m|R=r’,qm,c) under assumption B2, the fifth by A and B1, and the sixth by C. 
 
Note that among those with R=r: 
 
∑c E[Y1|R=r,c]P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c)   (2)  
 
And likewise, among those with R=r’: 
 
∑c E[Y1|R=r’,c]P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r’,m,qm,c]P(M=m|R=r’,qm,c)P(qm|R=r’,c)P(c)     (3) 
 
 
Alternatively, among those with R=r’: 
 
∑c E[Y1|R=r’,c]P(c) 
= ∑m,q_m,c E[Y1|R=r’,m,qv,qm,c]P(M=m|R=r’,qv,qm,c)P(qv|R=r’,qm,c)P(qm|R=r’,c)P(c)   (3*) 
 
 
Remark 1. Equations (1), (2), and (3) represent g-formulae for decomposition with time-fixed interventions. 
The distribution P(M=m|R=r’,qm,c) in (1) could be viewed as a marginalization of P(M=m|R=r’,qv,qm,c) over 
the distribution P(qv|R=r’,qm,c) rather than conditional independence between M and Qv given R=r’,qm, and c, 
as can be seen by contrasting the expressions (3) and (3*).  
 
Remark 2. The comparison to existing estimators on pages 9 to 13 are derived under the alternate 
identification formulae (1), (2), and (3*). 
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Estimation.  
 
Decomposition using Ratio of Mediator Probability Weights (RMPW) 
 
Let M be categorical with j levels mj. 
 
Among those with R=r we have that: 
 
∑c E[Y1(Gm|q_m,c = mj)|R=r,c]P(c) 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
                             ×
P(M = mj|R = r
′, qm, c)
P(M = mj|R = r, qv, qm, c)
 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c|R=r) 
                             ×
P(M = mj|R = r
′, qm, c)
P(M = mj|R = r, qv, qm, c)
×
P(c)
P(c|R=r)
 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c|R=r) 
                             ×
P(M = mj|R = r
′, qm, c)
P(M = mj|R = r, qv, qm, c)
×
P(R=r)
P(R=r|c)
 
 
= E[E[Y1 ×I(M=mj) ×I(R=r) × wr
rmpw
|qm,qv,c]]       (4a) 
 
Where wr
rmpw
=
P(M = mj|R = r
′, qm , c)
P(M = mj|R = r, qv, qm, c)
×
P(R=r)
P(R=r|c)
      (4b) 
 
The first equality is identified via eqn 1. 
 
Note that, among those with R=r we have: 
 
∑c E[Y|R=r,c]P(c) = E[E[Y1 ×I(R=r) × wr|qm,qv,c]]      (5a) 
 
Where wr =
P(R=r)
P(R=r|c)
          (5b) 
 
And among those with R=r’: 
 
∑c E[Y|R=r,c]P(c) = E[E[Y1 ×I(R=r’) × wr′|qm,c]]       (6a) 
 
Where wr
′ =
P(R=r′)
P(R=r′|c)
          (6b) 
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Thus, under the expressions and weights defined above, we have the general result: 
 
 The observed disparity  
 φobs=∑c E[Y1|R=r,c]P(c) - ∑c E[Y1|R=r’,c]P(c) 
            =  E[E[Y1 ×I(R=r) × wr|qm,qv, c]] – E[E[Y1 ×I(R=r’) × wr
′|qm,c]]   (7a) 
 
 The reduced disparity 
 φred=∑c E[Y1|R=r,c]P(c) - ∑c E[Y1(Gm|q_m,c=mj)|R=r,c]P(c)     
            = E[E[Y1 ×I(R=r) × wr|qm,qv,c]] – E[E[Y1 ×I(M=m) ×I(R=r) × wr
rmpw
|qm,qv,c]]  
(7b) 
 The residual disparity 
 φres=∑c E[Y1(Gm|q_m,c=mj)|R=r,c]P(c) - ∑c E[Y1|R=r’,c]P(c)     
            = E[E[Y1 ×I(M=m) ×I(R=r) × wr
rmpw
|qm,qv,c]] – E[E[Y1 ×I(R=r’) × wr
′|qm,c]]  
(7c) 
With weights defined as 
 
wr =
P(R=r)
P(R=r|c)
     
        
wr
′ =
P(R=r′)
P(R=r′|c)
   
 
wr
rmpw
=
P(M = mj|R = r
′, qm , c)
P(M = mj|R = r, qv, qm , c)
×
P(R = r)
P(R = r|c)
 
  
Contrast (7a) can be estimated as β1 in the weighted regression model with the observed data: 
 
E[Y1|R]=β0+β1R(r-r’) fit with weights wr for those with R=r and wr
′  for those with R=r’. 
 
Constrast (7b) can be estimated as β1 in the weighted regression model with a stacked dataset consisting of 
the original subset R=r (labelled as D=d) and a copy of the subset R=r (labelled as (D=d’). 
 
E[Y1|D]=β0+β1D(d-d’) fit with weights wr for those with D=d and wr
rmpw
 for those with D=d’. 
 
Contrast (7c) can be estimated as β1 in the weighted regression model with the observed data:  
 
E[Y1|R]=β0+β1R(r-r’) fit with weights wr
rmpw
 for those with R=r and wr
′  for those with R=r’. 
 
Remarks. 
 
The conditionality of the intervention G appears through the numerator in (4b). Any confounders Qv beyond 
the variables defined in C and Qm appear only in the denominator. Thus, the conditionality of the numerator 
will differ from the denominator whenever the intervention G does not condition on all of the confounders of 
M. 
  
 
 
 
 
 
 
 
 
 
 
29 
 
Decomposition using Inverse Odds Ratio Weights (IORW) 
 
Let M be categorical with j levels mj. 
 
Among those with R=r we have that: 
 
∑c E[Y1(Gm|q_m,c = mj)|R=r,c]P(c) 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=mj|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
                             ×
P(M = mj|R = r
′, qm, c)
P(M = mj|R = r, qv, qm, c)
 
 
= ∑m,q_m,q_v,c E[Y1|R=r,mj,qv,qm,c]P(M=m|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c|R=r) 
                             ×
P(M = mj|R = r
′, qm, c)
P(M = mj|R = r, qv, qm, c)
×
P(c)
P(c|R=r)
 
 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c|R=r) 
                             ×
P(R=r′,M=mj,qm,c)
P(R=r′,qm,c)
P(R=r,M=mj,qv,qm,c)
P(R=r,qv,qm,c)
×
P(R=r)
P(R=r|c)
 
 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r,qv,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c|R=r) 
                             ×
P(R=r′|mj,qm,c)
P(R=r|mj,qv,qm,c)
P(R=r′|qm,c)
P(R=r|qv,qm,c)
×
P(M=mj|qm,c)
P(M=mj|qv,qm,c)
×
P(R=r)
P(R=r|c)
 
 
= E[E[Y1 ×I(M=m) ×I(R=r) × wr
iorw|qm,qv,c]]       (8a) 
 
Where wr
iorw =
P(R=r′|mj,qm,c)
P(R=r|mj,qv,qm,c)
P(R=r′|qm,c)
P(R=r|qv,qm,c)
×
P(M=mj|qm,c)
P(M=mj|qv,qm,c)
×
P(R=r)
P(R=r|c)
      (8b) 
 
The first equality is identified via eqn 1. 
 
The third and sixth equalities show that the wr
iorw = wr
rmpw
 in the absence of model mis-specification. Thus, it 
follows that we can implement the inverse odds ratio weighting approach by following the estimation 
procedure outlined before with ratio of mediator weights, replacing wr
rmpw
 (4b) by wr
iorw (8b) 
 
Remarks. 
 
The conditionality of the intervention G appears through the numerators in (8b). Any confounders Qv beyond 
the variables defined in C and Qm appear only in the denominators. Thus, the conditionality of the numerators 
will differ from the denominators whenever the intervention G does not condition on all of the confounders of 
M. 
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Implementation 
 
Remark 3. The sketch for parametric g-computation in the main-text was based on models using the 
factorizations (1), (2), and (3). However, one can replace (3) with (3*). If that is done, the outcome models 
for blacks and whites would always condition on allowable and non-allowable covariates. Also, the target 
factor models would always condition on the allowable and non-allowable covariates among the observed 
scenarios for blacks and whites, but only condition on the allowables in the counterfactual scenario for blacks. 
This alternate specification can lead to issues with non-congeniality, as it may be difficult to specify models 
for P(M=m|R=r’,qm,c) [used for estimating the counterfactual scenario for blacks] and P(M=m|R=r’,qv,qm,c) 
[used for estimating the observed scenario for whites under (3*)] that are compatible with one another. This 
challenge does not arise when (3) is used because then only P(M=m|R=r’,qm,c) must be specified. 
 
Ratio of Mediator Probability Weighting 
 
The first component of the weight wr
rmpw
 is a ratio of two probabilities. The numerator could be estimated by 
fitting, among whites, a logistic regression model for the probability of treatment intensification M given the 
allowable covariates Qm and C. The denominator could be estimated by fitting an analogous model among 
blacks that further conditions on non-allowable confounders Qv. These models need not be compatible when 
fitted this way, separately for blacks and whites. The second component of the weight wr
rmpw
 could be 
obtained with logistic regression models for race R  that do and do not control for the outcome-allowable 
covariates C. The predicted values from these four models are used to obtain the weight wr
rmpw
 for each 
individual.  
 
A stacking procedure can be used to estimate the effects of interest. To obtain the disparity reduction (2) 
minus (1), the data from blacks with weight wr (5b) are stacked onto a copy from blacks with weight wr
rmpw
 
(4b) and labelled with a new variable called data origin (D; 1=original, 0=copy). The weighted mean 
difference in Y1 across data origin D estimates the disparity reduction. To obtain the disparity residual (1) 
minus (3), the data from blacks with weight wr
rmpw
 (4b) are stacked onto the data from whites with weight 
wr′  (6b). The weighted mean difference in Y1 across race R estimates the disparity residual. 
 
Inverse Odds Ratio Weighting 
 
The first component of wr
iorw  is a ratio of two odds. The numerator odds can be estimated by fitting logistic 
regressions for race given treatment intensification M, allowable covariates Qm and C with and without 
further control for non-allowable confounders Qv. For the denominator odds one can use similar models but 
without control for treatment intensification M. For the second and third components one can adapt what 
was described for the RMPW-style estimator, with the caveat that the models for treatment intensification M 
do not condition on race R. As noted in the main text, the estimation procedure is valid if all models are 
specified correctly, and special care should be taken to ensure that models are compatible with one another. 
For guidance, see the procedure proposed by Miles et al. Once all necessary models are fit, their predicted 
values are used to form individual weights. The stacking procedure described above is used but replacing 
wr
rmpw
 weights (4b) with wr
iorw weights (8b). 
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Relation to Existing Estimators (under identifying formulae (1), (2), and (3*)) 
 
Interventional Analogue of the Natural Indirect Effect 
 
Suppose we estimate the disparity reduction where C, the covariates deemed both outcome- and target-
allowable, includes all covariates. This leaves Qm empty because we have exhausted the potential covariates 
that could be deemed target-allowable. This leaves QV empty because we have exhausted the covariates 
needed to establish conditional exchangeability for M. The disparity reduction is identified by the non-
parametric expression of Pearl and the weighting estimators of Hong (2010) and (2015), Lange et al., and 
Tchetgen Tchetgen. 
 
Non-parametric 
 
φred = ∑m,l_0,x_i-v E[Y1|R=r,mj,l0, xi−v]{P(mj|R=r, l0, xi−v)−P(mj|R = r’, l0, xi−v)}P(l0, xi−v) 
 
A conditional expression is obtained by removing the integration over l0, xi−v. This expression is equivalent to 
the mediation formula of Pearl, which underlies the regression-based estimators of Valeri and VanderWeele, 
as well as the simulation-based estimators of Imai et al. and Wang et al. The marginal expression serves as the 
basis for the imputation estimator of Albert, and VanderWeele and Vansteelandt. 
 
Ratio of Mediator Probability Weighting 
 
φred = E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’)×I(M=mj) × wr
rmpw
|l0, xi−v]] 
 
Where wr =
P(R=r)
P(R=r|l0,xi−v)
,  wr
′ =
P(R=r′)
P(R=r′|l0,xi−v)
, and wr
rmpw
=
P(M = mj|R = r
′, l0, xi−v)
P(M = mj|R = r, l0, xi−v)
× wr 
 
A conditional expression is obtained by removing the outer expectation and setting wr = wr
′ = 1. The 
marginal and conditional versions are equivalent to the weighting approaches of Hong (2010) and (2015), 
while the marginal expressions are equivalent to that used in the natural effect models of Lange et al. 
 
Inverse Odds Ratio Weighting 
 
φred = E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’)×I(M=mj) × wr
iorw|l0, xi−v]] 
 
Where wr =
P(R=r)
P(R=r|l0,xi−v)
,  wr
′ =
P(R=r′)
P(R=r′|l0,xi−v)
, and wr
iorw =
P(R=r′|mj,l0,xi−v)
P(R=r|mj,l0,xi−v)
P(R=r′|l0,xi−v)
P(R=r|l0,xi−v)
× wr 
 
A conditional expression is obtained by removing the outer expectation and setting wr = wr
′ = 1. This is 
equivalent to the approach of Huber and related to the approach of Tchetgen Tchetgen. 
 
Interventional Analogue of the Path-Specific Indirect Effect I 
 
Suppose we estimate the disparity reduction where C, the covariates deemed both outcome- and target-
allowable, include Xi,ii. Qm is left empty so that no additional variables are considered target-allowable, and Qv 
includes all other variables needed to establish conditional exchangeability for M (i.e., L0,Xiii-v). The disparity 
reduction is identified by the non-parametric expression and weighting estimator for the interventional 
indirect effect of VanderWeele, Vansteelandt, and Robins. 
 
 
 
 
 
32 
 
Non-parametric 
 
φred=∑m,q_m,q_v,c E[Y1|R=r,m,l0,xi-v]{P(M = mj|R=r,l0,xi-v)−P(M =m|R=r’,xi,ii)}P(l0,xiii-v|R=r,xi,ii)P(xi,ii) 
 
A conditional expression is obtained by removing the integration over Xi,ii. This is equivalent to the expression 
of VanderWeele, Vansteelandt, and Robins under a stochastic intervention. 
 
Ratio of Mediator Probability Weighting 
 
φred= E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’) × wr
rmpw
|l0, xi−v]] 
 
Where wr =
P(R=r)
P(R=r|xi,ii)
,  wr
′ =
P(R=r′)
P(R=r′|xi,ii)
, and wr
rmpw
=
P(M = mj|R = r
′, xi,ii)
P(M = mj|R = r, l0, xi−v)
× wr 
 
A conditional expression is obtained by conditioning the outer expectation on xi,ii and setting wr = wr
′ = 1. 
This is equivalent to the approach of VanderWeele, Vansteelandt, and Robins under a stochastic intervention. 
Note that they express P(M = mj|R = r
′, xi,ii) as ∑ P(M = mj|R = r
′, l0, xi−v)P(l0xiii−v l0xiii−v|R = r
′, xi,ii) to 
emphasize that P(M = mj|R = r
′, xi,ii) represents a marginalization of P(M = mj|R = r
′, l0, xi−v) over 
P(l0, xiii−v|R = r
′, xi,ii) rather than conditional independence of M and {L0, Xiii−v} given R = r
′ and Xi,ii. 
 
Interventional Analogue of the Path-Specific Indirect Effect II 
 
The simulation-based estimator of the interventional indirect effect of Vansteelandt and Daniel does not 
generally estimate the disparity reduction, but rather a contrast of two interventions. 
 
To see this, consider two stochastic interventions. The first intervention, Gm|qmc
r , assigns treatment 
intensification, the targeted factor, according to its conditional distribution among blacks given the 
allowables C and Qm, defined as P(M = m|R = r, qm , c). The second intervention, Gm|qmc
r′ , assigns treatment 
intensification, the targeted factor, according to its conditional distribution among whites given the 
allowables C and Qm, defined as P(M = m|R = r
′, qm, c). 
 
According to assumptions A, B1, and C, under the first intervention, the proportion of blacks with 
uncontrolled hypertension, standardized by the outcome-allowable covariates, is:  
 
∑c E[Y1(Grm|q_m,c =m)|R=r,c]P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,Grm|q_m,c=m,qm,c]P(Grm|q_m,c=m|R=r,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,qm,c]P(Grm|q_m,c=m|R=r,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,c E[Y1(m)|R=r,qm,c]P(M=m|R=r,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1(m)|R=r,qv,qm,c]P(M=m|R=r,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1(m)|R=r,m,qv,qm,c]P(M=m|R=r,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c)   (9) 
 
According to equation (1), under assumptions A, B1, B2, and C, under the second intervention, the proportion 
of blacks with uncontrolled hypertension, standardized by the outcome-allowable covariates, is:  
 
∑c E[Y1(Gr’m|q_m,c =m)|R=r,c]P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]P(M=m|R=r’,qm,c)P(qv|R=r,qm,c)P(qm|R=r,c)P(c)    
 
The difference in uncontrolled hypertension among blacks comparing the two interventions is: 
 
∑c E[Y1(Grm|q_m,c =m)|R=r,c]P(c) - ∑c E[Y1(Gr’m|q_m,c =m)|R=r,c]P(c) 
= ∑m,q_m,q_v,c E[Y1|R=r,m,qv,qm,c]{P(M=m|R=r,qm,c)- P(M=m|R=r’,qm,c)}P(qv|R=r,qm,c)P(qm|R=r,c)P(c) (10) 
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Note that (10) not generally equal to the disparity reduction (2) minus (1) because the first intervention 
Gm|qmc
r  breaks any dependence of treatment intensification M on non-allowables Qv, whereas in the observed 
scenario this dependence is present. They are equivalent when P(M=m|R=r,qm,c) = P(M=m|R=r,qv,qm,c). 
 
Suppose we estimate the disparity reduction where C, the covariates deemed both outcome- and target-
allowable include Xi,ii. Qm is left empty so that no additional variables are considered target-allowable, and Qv 
includes all other variables needed to establish conditional exchangeability for M (i.e., L0,Xiii-v). Now, under 
these allowability choices, the difference between the first and second interventions is: 
 
∑m,l0,xi-v E[Y1|R=r,m,l0,xi-v]{P(M=m|R=r,xi,ii)-P(M=m|R=r’,xi,ii)}P(l0,xiii-v|R=r,xi,ii)P(xi,ii)      
  
This last expression is equivalent to the identification formula for the interventional indirect effect of 
Vansteelandt and Daniel for the terminal mediator when applied to our motivating example. Again, this does 
not estimate the disparity reduction because P(M=m|R=r,l0,xi-v)≠P(M=m|R=r,xi,ii). 
 
Interventional Analogue of the Path-Specific Indirect Effect III 
 
Suppose we estimate the disparity reduction where C, the covariates deemed both outcome- and target-
allowable, include Xi,ii. Qm, the additional covariates deemed target allowable, includes all other covariates 
(i.e., L0,Xiii-v). Qv is left empty since conditional exchangeability among blacks has been established for M given 
Qm and C. The disparity reduction is identified by the non-parametric expressions and weighting approach of 
Zheng and van der Laan (2017) and Miles et al. 
 
Non-parametric 
 
φred=∑m,l_0,x_i-v E[Y1|R=r,mj,l0, xi−v]{P(mj|R=r, l0, xi−v)−P(mj|R = r’, l0, xi−v)} 
                               × P(l0, xiii−v|R = r, xi,ii)P(xi,ii) 
 
A conditional expression is obtained by removing the integration over xi,ii. This is equivalent to the non-
parametric expression of a path-specific effect discussed in Jackson 2018. 
 
Ratio of Mediator Probability Weighting 
 
φred= E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’) × wr
rmpw
|l0, xi−v]] 
 
Where wr =
P(R=r)
P(R=r|xi,ii)
,  wr
′ =
P(R=r′)
P(R=r′|xi,ii)
, and wr
rmpw
=
P(M = mj|R = r
′, l0, xi−v)
P(M = mj|R = r, l0, xi−v)
× wr 
 
A conditional expression is obtained by conditioning the outer expectation on xi,ii and setting wr = wr
′ = 1. 
This is related to the weighting approach of Zheng and Van der Laan (2017). 
 
Inverse Odds Ratio Weighting 
 
φred= E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’)×I(M=mj) × wr
iorw|l0, xi−v]] 
 
Where wr =
P(R=r)
P(R=r|xi,ii)
,  wr
′ =
P(R=r′)
P(R=r′|xi,ii)
, and wr
iorw =
P(R=r′|mj,l0,xi−v)
P(R=r|mj,l0,xi−v)
P(R=r′|l0,xi−v)
P(R=r|l0,xi−v)
× wr 
 
A conditional expression is obtained by conditioning the outer expectation on xi,ii and setting wr = wr
′ = 1. 
This is equivalent to the “m-ratio” in the weighting approach proposed by Miles et al. Under a no-interaction 
assumption (see Jackson 2018) their approach estimates the non-parametric expression above. 
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“Detailed” Oaxaca-Blinder Decomposition 
 
Suppose we estimate the disparity reduction where no covariates are deemed outcome- or target-allowable. 
All covariates are included in Qv to establish exchangeability for M. The disparity reduction is identified by a 
“detailed” Oaxaca-Blinder Decomposition implemented with linear models. 
 
The non-parametric formulae are: 
 
φred=∑ l_0,x_i-v E[Y1|R=r, mj,xi-v]{P(M = mj|R=r,l0,xi-v)−P(M = mj|R=r’)}P(l0,xi-v|R=r) 
 
Consider the following linear models: 
 
E[Y1|R = r, mj, xi−v] = β0
r + ∑ β1j
r
j≠ref I(M = mj) + β2
r L0 + ∑ β3k
r Xk
v
k=i   
 
E[Y1|R = r
′, mj, xi−v] = β0
r′ + ∑ β1j
r′
j≠ref I(M = mj) + β2
r′L0 + ∑ β3k
r′ Xk
v
k=i   
 
It follows from the arguments of Jackson and VanderWeele 2018 we that: 
 
φred = ∑ β1j
r {P(mj|R = r) − P(mj|R = r
′)}j≠ref  
 
This is the typical formulation of a detailed Oaxaca-Blinder Decomposition under linear models. Alternate 
implementations of the Oaxaca-Blinder Decomposition make different allowability choices. For example, 
suppose we estimate the disparity reduction where no covariates are deemed outcome-allowable but all 
covariates are considered target-allowable, leaving Qv empty. The disparity reduction is identified by the 
following non-parametric formula which leads to adaptations of the weighting estimators of Dinardo et al. (a 
form of ratio of mediator probability weighting) and Barsky et al. (a form of inverse odds ratio weighting). 
 
Non-parametric 
 
φred=∑m,l_0,x_i-v E[Y1|R = r, mj, l0, xi−v]{P(mj|R=r, l0, xi−v)−P(mj|R = r’, l0, xi−v)}P(l0, xi−v|R = r) 
 
Ratio of Mediator Probability Weighting 
 
φred= E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’) × wr
rmpw
|l0, xi−v]] 
 
Where wr = wr
′ = 1 and wr
rmpw
=
P(M = mj|R = r
′, l0, xi−v)
P(M = mj|R = r, l0, xi−v)
× wr 
 
This is equivalent to an extension of the weighting approach proposed by Dinardo, Fortin and Lemieux where 
the conditioning events of the numerator and denominator include all covariates. 
 
Inverse Odds Ratio Weighting 
 
φred= E[E[Y1 ×I(R=r) × wr|l0, xi−v]] – E[E[Y1 ×I(R=r’)×I(M=mj) × wr
iorw|l0, xi−v]] 
 
Where wr = wr
′ = 1 and wr
iorw =
P(R=r′|mj,l0,xi−v)
P(R=r|mj,l0,xi−v)
P(R=r′|l0,xi−v)
P(R=r|l0,xi−v)
× wr 
 
This is equivalent to an extension of the weighting approach proposed by Barsky et al., and also one discussed 
by Dinardo, Fortin and Lemieux, where the conditioning events of the numerator and denominator include all 
covariates. 
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